The growth of certain aggressive brain tumors can be halted by cutting off their access to a signaling molecule produced by the brain’s nerve cells, according to a new study by researchers at the Stanford University School of Medicine.
The growth of certain aggressive brain tumors can be halted by cutting off their access to a signaling molecule produced by the brain’s nerve cells, according to a new study by researchers at the Stanford University School of Medicine.
When the signaling molecule neuroligin-3 was absent, or when its signal was interrupted with medication, human cancers called high-grade gliomas could not spread in the brains of mice, the researchers found.
The study was published online Sept. 20 in Nature. Graduate student Humsa Venkatesh is the study’s lead author.
Continue reading at Stanford University
